Canadian Drug Pricing Reforms Could Lead To Medicine Shortages
Drug pricing reform in Canada could prompt companies to launch elsewhere or see drugs diverted to the US.
You may also be interested in...
Some measures aimed at reducing medicine prices in Canada have been dropped, to the relief of the pharmaceutical industry.
Industry has have welcomed another delay to the implementation of drug pricing reforms that aim to lower Canadian drugs prices.
The R&D based pharmaceutical industry would welcome changes to guidelines that will operationalize controversial new pricing regulations in Canada but industry experts say more is needed.